XAIR

Beyond Air, Inc.

3.75 USD

Last updated Sep 12, 01:49 UTC

Yesterday HIGH

$3.19

Yesterday LOW

$3.06

52w HIGH

$95.6

52w LOW

$3.06

EPS

-11.00

PE

-0.34

Next Earnings

Nov 9, 2026

Overview News Government Trades Fundamentals

Beyond Air, Inc. stock is down -45.81% since 30 days ago. The next earnings date is Nov 9, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 7 September’s closed higher than August. 100% of analysts rate it a buy.

Benzinga Newsdesk

Fri Jun 26, 2026

Beyond Air Sees Calendar Year 2026 Sales Guidance of $8.000M

Beyond Air (NASDAQ:XAIR) sees Calendar Year 2026 sales of $8.000 million
Benzinga Newsdesk

Fri Jun 26, 2026

Beyond Air Sees Calendar Year 2027 Sales $16.000M-$18.000M

Beyond Air (NASDAQ:XAIR) sees Calendar Year 2027 sales of $16.000 million-$18.000 million
Benzinga Insights

Fri Jun 26, 2026

Earnings Scheduled For June 26, 2026

Companies Reporting Before The Bell • Beyond Air (NASDAQ:XAIR) is estimated to report quarterly loss at $0.56 per share on revenue of $2.30 million. • Apogee Enterprises (NASDAQ:APOG) is expected to report quarterly
Benzinga Newsdesk

Fri Jun 26, 2026

Beyond Air Q4 EPS $(0.77) Misses $(0.57) Estimate, Sales $1.907M Miss $2.296M Estimate

Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.57) by 35.09 percent. This is a 57.22 percent increase over losses of $(1.80) per share from the
Avi Kapoor

Fri Jun 26, 2026

Nasdaq Falls For Fourth Day Amid Decline In Apple Shares: Investor Sentiment Declines, Greed Index Remains In ‘Fear’ Zone

The CNN Fear & Greed Index, measuring market sentiment, showed a slight decline on Thursday, remaining in the Fear zone at 25.5.
Avi Kapoor

Fri Jun 26, 2026

Apogee Enterprises, Synaptics And 3 Stocks To Watch Heading Into Friday

U.S. stock futures are down, but some stocks to watch today include Apogee, BitGo, Cineverse, Synaptics and Beyond Air.
Benzinga Newsdesk

Mon Jun 1, 2026

Beyond Air Granted Nasdaq Panel Extension To Regain Compliance By July 31

Beyond Air, Inc. (NASDAQ:XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that the Nasdaq Hearings
Benzinga Insights

Tue May 26, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Newsdesk

Mon Apr 20, 2026

Beyond Air Subsidiary Beyond Cancer Announces Updated Follow-Up Data From Its Phase 1 UNO Trial, Notes That As Of February 2, Six Of Ten Patients Remain Alive 22-40 Months After A Single UNO Injection

The Phase 1 trial (NCT05351502) was a clinical proof-of-concept trial that assessed the intratumoral administration of UNO in patients with unresectable cutaneous or subcutaneous histologically confirmed primary or
Benzinga Newsdesk

Fri Apr 17, 2026

Beyond Air Granted U.S. Patent Titled 'System And Method For Delivery Of Gas To A Tissue' To Treat Tumors

https://x.com/PatentGrants/status/2045229993731776669